Enrolling 72 Patients within 8 Months for a Phase 3 Cardiology Trial

Science 37 supported a Phase 3 atrial fibrillation trial, overcoming strict protocol criteria, an older target demographic, and initial enrollment delays through targeted process improvements and close sponsor collaboration.